These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22137999)

  • 1. Development of a pilot-scale manufacturing process for protein-coated microcrystals (PCMC): mixing and precipitation - part I.
    König C; Bechtold-Peters K; Baum V; Schultz-Fademrecht T; Bassarab S; Steffens KJ
    Eur J Pharm Biopharm; 2012 Apr; 80(3):490-8. PubMed ID: 22137999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
    Dong Y; Ng WK; Hu J; Shen S; Tan RB
    Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple confined impingement jets mixer for flash nanoprecipitation.
    Han J; Zhu Z; Qian H; Wohl AR; Beaman CJ; Hoye TR; Macosko CW
    J Pharm Sci; 2012 Oct; 101(10):4018-23. PubMed ID: 22777753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled antisolvent precipitation of spironolactone nanoparticles by impingement mixing.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Int J Pharm; 2011 May; 410(1-2):175-9. PubMed ID: 21397674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
    Gikanga B; Chen Y; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
    Khosravani A; Parker MC; Parton R; Coote J
    Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development in modeling submicron particle formation in two phases flow of solvent-supercritical antisolvent emulsion.
    Dukhin SS; Shen Y; Dave R; Pfeffer R
    Adv Colloid Interface Sci; 2007 Oct; 134-135():72-88. PubMed ID: 17568550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of recombinant proteins from culture broth by co-precipitation with an amino acid carrier to form stable dry powders.
    Moore BD; Deere J; Edrada-Ebel R; Ingram A; van der Walle CF
    Biotechnol Bioeng; 2010 Aug; 106(5):764-73. PubMed ID: 20229511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixing characteristics of mixers in flow analysis. Application to two-dimensional detection in ion chromatography.
    Liao H; Dasgupta PK; Srinivasan K; Liu Y
    Anal Chem; 2015 Jan; 87(1):793-800. PubMed ID: 25426864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling drug nanoparticle formation by rapid precipitation.
    D'Addio SM; Prud'homme RK
    Adv Drug Deliv Rev; 2011 May; 63(6):417-26. PubMed ID: 21565233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization.
    Matteucci ME; Hotze MA; Johnston KP; Williams RO
    Langmuir; 2006 Oct; 22(21):8951-9. PubMed ID: 17014140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
    Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
    Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals.
    Xia D; Gan Y; Cui F
    Curr Pharm Des; 2014; 20(3):408-35. PubMed ID: 23651396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique.
    Douroumis D; Fahr A
    Eur J Pharm Biopharm; 2006 Jun; 63(2):173-5. PubMed ID: 16621482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.